Journal of Viral Hepatitis

Cover image for Vol. 19 Issue 9

September 2012

Volume 19, Issue 9

Pages 601–676

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C (pages 608–614)

      Miyuki Miyashita, Takayoshi Ito, Masashi Sakaki, Atsushi Kajiwara, Hisako Nozawa, Kazumasa Hiroishi, Mariko Kobayashi, Hiromitsu Kumada and Michio Imawari

      Version of Record online: 28 JAN 2012 | DOI: 10.1111/j.1365-2893.2011.01580.x

      • image
    2. An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin (pages 615–622)

      C. Kondo, M. Atsukawa, A. Tsubota, N. Itokawa, T. Fukuda, Y. Matsushita, H. Kidokoro, T. Kobayashi, Y. Narahara, K. Nakatsuka, H. Kanazawa and C. Sakamoto

      Version of Record online: 9 FEB 2012 | DOI: 10.1111/j.1365-2893.2011.01584.x

      • image
      • image
      • image
    3. Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3 (pages 623–634)

      S. Pianko, S. Zeuzem, W.-L. Chuang, G. R. Foster, S. K. Sarin, R. Flisiak, C.-M. Lee, P. Andreone, T. Piratvisuth, S. Shah, A. Sood, J. George, M. Gould, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, Y. Li, M. Pang, Y. Yin, G. Feutren, I. M. Jacobson and for the B2202 Study Team

      Version of Record online: 21 MAR 2012 | DOI: 10.1111/j.1365-2893.2012.01586.x

      • image
      • image
      • image
    4. Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C (pages 640–649)

      E. Villa, C. Cammà, A. Di Leo, A. Karampatou, M. Enea, S. Gitto, V. Bernabucci, L. Losi, N. De Maria, B. Lei, A. Ferrari, R. Vukotic, P. Vignoli, M. Rendina and A. Francavilla

      Version of Record online: 15 MAR 2012 | DOI: 10.1111/j.1365-2893.2012.01593.x

      • image
    5. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients (pages 650–653)

      E. Riva, C. Scagnolari, K. Monteleone, C. Selvaggi, A. Picardi, C. Mazzarelli, E. Pizzigallo, B. Vincenzi, A. Carducci, S. Antonaci, G. Giannelli and G. Antonelli

      Version of Record online: 1 APR 2012 | DOI: 10.1111/j.1365-2893.2012.01606.x

      • image
    6. Noninvasive assessment of liver fibrosis via spleen stiffness measurement using acoustic radiation force impulse sonoelastography in patients with chronic hepatitis B or C (pages 654–663)

      S.-H. Chen, Y.-F. Li, H.-C. Lai, J.-T. Kao, C.-Y. Peng, P.-H. Chuang, W.-P. Su and I.-P. Chiang

      Version of Record online: 15 FEB 2012 | DOI: 10.1111/j.1365-2893.2012.01588.x

      • image
      • image
      • image
    7. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies (pages 664–673)

      B. Niedre-Otomere, A. Bogdanova, D. Skrastina, A. Zajakina, R. Bruvere, V. Ose, W. H. Gerlich, H. Garoff, P. Pumpens, D. Glebe and T. Kozlovska

      Version of Record online: 17 MAY 2012 | DOI: 10.1111/j.1365-2893.2012.01594.x

      • image
      • image
      • image
      • image
      • image

SEARCH

SEARCH BY CITATION